-
Blood and Lymphatic Cancer: Targets and Therapy
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Blood and Lymphatic Cancer: Targets and Therapy
(25,487) Views
1179-9889
Blood and Lymphatic Cancer: Targets and Therapy is an international, peer-reviewed, open access journal focusing on blood and lymphatic cancer research, identification of therapeutic targets and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient. Specific topics covered in the journal include:
- Epidemiology, detection and screening
- Cellular research and biomarkers
- Identification of biotargets and agents with novel mechanisms of action
- Optimal clinical use of existing anticancer agents, including combination therapies
- Radiation, surgery, bone marrow transplantation
- Palliative care
- Patient adherence, quality of life, satisfaction
- Health economic evaluations
-
Call For Submissions
Submit Original Research Article, Review, Case Report, or Rapid Communication in Blood and Lymphatic Cancer: Targets and Therapy




